pGL3-OF (mutant TCF-4 sites) Citations (11)
Originally described in: The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW Cancer Res. 2000 Mar 15. 60(6):1671-6. PubMed
Articles Citing pGL3-OF (mutant TCF-4 sites)
| Articles |
|---|
| Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Kleeff J, Maruyama H, Friess H, Buchler MW, Falb D, Korc M. Biochem Biophys Res Commun. 1999 Feb 16;255(2):268-73. PubMed |
| miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. Shen G, Jia H, Tai Q, Li Y, Chen D. Carcinogenesis. 2013 Jan;34(1):211-9. doi: 10.1093/carcin/bgs320. Epub 2012 Oct 20. PubMed |
| Smad6 suppresses the growth and self-renewal of hepatic progenitor cells. Ding ZY, Liang HF, Jin GN, Chen WX, Wang W, Datta PK, Zhang MZ, Zhang B, Chen XP. J Cell Physiol. 2014 May;229(5):651-60. doi: 10.1002/jcp.24488. PubMed |
| Glucocorticoid Receptor beta Acts as a Co-activator of T-Cell Factor 4 and Enhances Glioma Cell Proliferation. Wang Q, Lu PH, Shi ZF, Xu YJ, Xiang J, Wang YX, Deng LX, Xie P, Yin Y, Zhang B, Mu HJ, Qiao WZ, Cui H, Zou J. Mol Neurobiol. 2014 Oct 10. PubMed |
| miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Hu S, Zheng Q, Wu H, Wang C, Liu T, Zhou W. Life Sci. 2017 May 15;177:15-19. doi: 10.1016/j.lfs.2017.03.019. Epub 2017 Mar 27. PubMed |
| Depletion of MUC5B mucin in gastrointestinal cancer cells alters their tumorigenic properties: implication of the Wnt/beta-catenin pathway. Lahdaoui F, Messager M, Vincent A, Hec F, Gandon A, Warlaumont M, Renaud F, Leteurtre E, Piessen G, Jonckheere N, Mariette C, Van Seuningen I. Biochem J. 2017 Nov 1;474(22):3733-3746. doi: 10.1042/BCJ20170348. PubMed |
| DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/beta-catenin pathway. Zhang T, Ma Z, Liu L, Sun J, Tang H, Zhang B, Zou Y, Li H. Cell Death Dis. 2018 Jun 4;9(6):675. doi: 10.1038/s41419-018-0591-0. PubMed |
| CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression. Zheng L, Liang X, Li S, Li T, Shang W, Ma L, Jia X, Shao W, Sun P, Chen C, Jia J. EBioMedicine. 2018 Dec;38:69-78. doi: 10.1016/j.ebiom.2018.11.009. Epub 2018 Nov 16. PubMed |
| Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/beta-Catenin Signaling. Ping MH. Cancer Manag Res. 2020 Nov 17;12:11773-11782. doi: 10.2147/CMAR.S270544. eCollection 2020. PubMed |
| FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway. He S, Wang W, Wan Z, Shen H, Zhao Y, You Z, Liu J, Zhu L. Oncogenesis. 2021 Jan 9;10(1):6. doi: 10.1038/s41389-020-00301-y. PubMed |
| Exosome-derived microRNA-433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non-small cell lung cancer. Liu B, Zhang R, Zhu Y, Hao R. Oncol Lett. 2021 Aug;22(2):607. doi: 10.3892/ol.2021.12868. Epub 2021 Jun 15. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.